SYNKIR
Live / Registered — Registered (as of 03 Jun 2025)
What this means for you
Registered since 03 Jun 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90099742
- Registration number
- 7819263
- Mark type
- Stylized text
- Filed
- 07 Aug 2020
- Published for opposition
- 20 Jul 2021
- Registered
- 03 Jun 2025
- Attorney of record
- Christopher D. Olszyk, Jr.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the treatment of cancer for use in Chimeric Antigen Receptor (CAR) T-Cell Therapy
Owner
- Verismo Therapeutics, Inc., Philadelphia, PA, US
- Verismo Therapeutics, Inc., Philadelphia, PA, US
- Verismo Therapeutics, Inc., Mount Laurel, NJ, US
Prosecution history
- 21 Oct 2025 — NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
- 30 Sept 2025 — CORRECTION UNDER SECTION 7 - PROCESSED
- 22 Sept 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 10 Jun 2025 — TEAS SECTION 7 REQUEST RECEIVED
- 03 Jun 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 03 Jun 2025 — REGISTERED-PRINCIPAL REGISTER
- 12 May 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 12 May 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 26 Feb 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 26 Feb 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 26 Feb 2025 — ASSIGNED TO LIE
- 18 Feb 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 18 Nov 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 18 Nov 2024 — NON-FINAL ACTION E-MAILED
- 18 Nov 2024 — SU - NON-FINAL ACTION - WRITTEN